Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Asensus Surgical Inc (ASXC)

Asensus Surgical Inc (ASXC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Asensus Surgical (ASXC) Reports Q2 Loss, Misses Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 16.67% and -32.39%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

ASXC : 1.9800 (+1.54%)
Will Asensus Surgical (ASXC) Report Negative Earnings Next Week? What You Should Know

Asensus Surgical (ASXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ASXC : 1.9800 (+1.54%)
Surgalign vs. Asensus Surgical: Which Medical Equipment Stock is a Better Buy?

The medical equipment industry has been growing at a healthy clip this year, with rising demand for elective surgeries that had been on hold during the worst of the COVID-19 pandemic last year. So, two...

SRGA : 1.3800 (-4.83%)
ASXC : 1.9800 (+1.54%)
Abbott (ABT) Downgrades 2021 Outlook on Lower Testing Demand

Abbott's (ABT) revised 2021 forecast continues to reflect strong, double-digit EPS growth despite lower COVID-19 testing demand.

COO : 436.60 (-1.39%)
ABT : 126.79 (-0.51%)
NVST : 42.53 (-2.12%)
ASXC : 1.9800 (+1.54%)
Myriad Genetics (MYGN) Sells myPath to Focus on Core Units

Myriad Genetics' (MYGN) new divesture will provide the company with growth capital for future investments.

COO : 436.60 (-1.39%)
MYGN : 33.72 (+3.37%)
LH : 295.93 (-0.30%)
ASXC : 1.9800 (+1.54%)
Quest Diagnostics (DGX) Buys Outreach Lab, Widens Midwest Base

Mercy's outreach laboratory services are set to get integrated into Quest Diagnostics' (DGX) full-service laboratory in Lenexa, KS.

DGX : 154.77 (-0.15%)
COO : 436.60 (-1.39%)
NVST : 42.53 (-2.12%)
ASXC : 1.9800 (+1.54%)
Here's Why You Should Add STERIS (STE) to Your Portfolio

Investors are optimistic about STERIS (STE) owing to strong segmental performance and huge growth potential in healthcare and pharmaceutical industries.

COO : 436.60 (-1.39%)
STE : 215.09 (-0.15%)
NVST : 42.53 (-2.12%)
ASXC : 1.9800 (+1.54%)
Cocrystal Pharma Announces the Passing of Chairman, CEO and Co-founder Dr. Gary Wilcox

With great sadness, Cocrystal Pharma, Inc. (Nasdaq: COCP), ("Cocrystal" or the "Company") announces that Gary Wilcox, Ph.D., Chairman, CEO and co-founder, suddenly passed away Wednesday, May 26 at the...

COCP : 1.0500 (-2.78%)
OPK : 3.94 (+3.14%)
GPX : 20.71 (unch)
ASXC : 1.9800 (+1.54%)
Thinking about buying stock in SOS, GameStop, New Oriental Education, Asensus Surgical, or Nabriva Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SOS, GME, EDU, ASXC, and NBRV.

ASXC : 1.9800 (+1.54%)
NBRV : 1.1500 (unch)
EDU : 1.9000 (+1.06%)
GME : 204.97 (-0.68%)
SOS : 2.65 (+2.32%)
The Autism Spectrum Disorders (ASD) Market Is Projected To Reach $4.53 Billion By 2026

, /PRNewswire/ -- Autism spectrum disorder (ASD) represents a group of neurodevelopmental disorders or disabilities; it is a heritable and a polygenic disorder. Autism spectrum disorder is lifelong and...

GWHP : 0.2800 (+11.96%)
SYBX : 3.29 (+3.13%)
ADMS : 5.05 (+6.32%)
MNKD : 4.53 (-0.66%)
UTHR : 200.08 (-2.47%)
ASXC : 1.9800 (+1.54%)

Barchart Exclusives

Natural Gas- Higher Multi-Year Highs
Natural gas has been making higher lows over the past fifteen months. The energy commodity began making higher multi-year highs in June 2021. With the peak season for demand on the horizon, the price is trading above $5, a level not seen since February 2014. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar